Human Genome Epidemiology Literature Finder
Records 1 - 20 (of 20 Records) |
Query Trace: Neoplasms and ITGB3[original query] |
---|
No association of breast cancer risk with integrin beta3 (ITGB3) Leu33Pro genotype. British journal of cancer 2005 Jul 93 (1): 167-71. Bojesen S E, Tybjaerg-Hansen A, Axelsson C K, Nordestgaard B |
Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk. Breast cancer research and treatment 2006 May 97 (1): 67-72. Langsenlehner Uwe, Renner Wilfried, Yazdani-Biuki Babak, Eder Tanja, Wascher Thomas C, Paulweber Bernhard, Clar Heimo, Hofmann Günter, Samonigg Hellmut, Krippl Pet |
Integrin beta3 Leu33Pro polymorphism increases BRCA1-associated ovarian cancer risk. Journal of medical genetics 2007 Jun 44 (6): 408-11. Jakubowska Anna, Gronwald Jacek, Menkiszak Janusz, Górski Bohdan, Huzarski Tomasz, Byrski Tomasz, Edler Lutz, Lubinski Jan, Scott Rodney J, Hamann U |
Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker. Carcinogenesis 2008 Jun . Brendle A, Lei H, Brandt A, Johansson R, Enquist K, Henriksson R, Hemminki K, Lenner P, Försti A |
Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers? European journal of cancer (Oxford, England : 1990) 2009 Mar 45 (5): 837-42. Jakubowska Anna, Jaworska Katarzyna, Cybulski Cezary, Janicka Anna, Szyma?ska-Pasternak Jolanta, Lener Marcin, Narod Steven A, Lubi?ski Jan, |
Integrin alpha-2 and beta-3 gene polymorphisms and colorectal cancer risk. International journal of colorectal disease 2009 Feb 24 (2): 159-63. Gerger Armin, Hofmann Günter, Langsenlehner Uwe, Renner Wilfried, Weitzer Werner, Wehrschütz Martin, Wascher Thomas, Samonigg Hellmut, Krippl Pet |
The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers. Breast cancer research and treatment 2010 Jun 121 (3): 639-49. Jakubowska Anna, Rozkrut Dominik, Antoniou Antonis, Hamann Ute, Lubinski J |
Analysis of common germline polymorphisms as prognostic factors in patients with lymph node-positive breast cancer. Journal of cancer research and clinical oncology 2010 Dec 136 (12): 1813-9. Knechtel Gudrun, Hofmann Günter, Gerger Armin, Renner Wilfried, Langsenlehner Tanja, Szkandera Joanna, Wolf Gerald, Samonigg Hellmut, Krippl Peter, Langsenlehner U |
Integrin beta-3 L33P: a new insight into the pathogenesis of chronic oxaliplatin-induced peripheral neuropathy? European journal of neurology : the official journal of the European Federation of Neurological Societies 2010 Jul 17 (7): 963-8. Antonacopoulou A G, Argyriou A A, Scopa C D, Kottorou A, Kominea A, Peroukides S, Kalofonos H |
Single nucleotide polymorphisms of integrin alpha-2 and beta-3 genes are not associated with relapse-free and overall survival in colorectal cancer patients. Anticancer research 2011 Apr 31 (4): 1373-7. Hofmann Günter, Langsenlehner Uwe, Langsenlehner Tanja, Glehr Matthias, Gerger Armin, Absenger Gudrun, Szkandera Joanna, Fuerst Florentine, Samonigg Hellmut, Krippl Peter, Renner Wilfri |
Investigation of ICAM-1 and ß3 integrin gene variations in patients with brain tumors. Asian Pacific journal of cancer prevention : APJCP 2013 14 (10): 5929-34. Yilmaz Umit, Zeybek Umit, Kahraman Ozlem Timirci, Kafadar Ali Metin, Toptas Bahar, Yamak Nesibe, Celik Faruk, Yaylim Ilh |
SNPs in microRNA-binding sites in the ITGB1 and ITGB3 3'-UTR increase colorectal cancer risk. Cell biochemistry and biophysics 2014 Sep 70 (1): 601-7. Ye Pingjiang, Li Zhenjun, Jiang Huafeng, Liu T |
Association between polymorphisms of microRNA-binding sites in integrin genes and gastric cancer in Chinese Han population. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Apr 36 (4): 2785-92. Song Xingbo, Zhong Huiyu, Zhou Juan, Hu Xuejiao, Zhou Yi, Ye Yuanxin, Lu Xiaojun, Wang Jun, Ying Binwu, Wang Lanl |
Integrin genetic variants and stage-specific tumor recurrence in patients with stage II and III colon cancer. The pharmacogenomics journal 2015 Jun 15 (3): 226-34. Bohanes P, Yang D, Loupakis F, LaBonte M J, Gerger A, Ning Y, Lenz C, Lenz F, Wakatsuki T, Zhang W, Benhaim L, El-Khoueiry A, El-Khoueiry R, Lenz H |
Distinct genotype-dependent differences in transcriptome responses in humans exposed to environmental carcinogens. Carcinogenesis 2015 Aug . Espín-Pérez Almudena, de Kok Theo M C M, Jennen Danyel G J, Hendrickx Diana M, De Coster Sam, Schoeters Greet, Baeyens Willy, van Larebeke Nicolas, Kleinjans Jos C |
Coexpression and expression quantitative trait loci analyses of the angiogenesis gene-gene interaction network in prostate cancer. Translational cancer research 2016 Oct 5 (Suppl 5): S951-S963. Lin Hui-Yi, Cheng Chia-Ho, Chen Dung-Tsa, Chen Y Ann, Park Jong |
Identification of prognostic and immune-related gene signatures in the tumor microenvironment of endometrial cancer. International immunopharmacology 2020 Sep 88 106931. Wang Guangwei, Wang Dandan, Sun Meige, Liu Xiaofei, Yang Qi |
An inflammatory response-related gene signature associated with immune status and prognosis of acute myeloid leukemia. American journal of translational research 2022 8 14 (7): 4898-4917. Wu Xin, Li Shiqin, Chen Dongjie, Zheng Guiping, Zhang Zhaohua, Li Zian, Sun Xiaoying, Zhao Qiangqiang, Xu Jingju |
The association between two genetic polymorphisms in ITGB3 and increase risk of venous thromboembolism in cancer patients in Eastern Province of Saudi Arabia. Saudi journal of biological sciences 2022 1 29 (1): 183-189. Alsulaim Asma Y, Azam Faisal, Sebastian Tunny, Mahdi Hassan Fathelrahman, AbdulAzeez Sayed, Borgio J Francis, Alzahrani Faisal |
An Integrated Computational Analysis of High-Risk SNPs in Angiopoietin-like Proteins (ANGPTL3 and ANGPTL8) Reveals Perturbed Protein Dynamics Associated with Cancer. Molecules (Basel, Switzerland) 2023 6 28 (12): . Sajid Iqbal, Farida Begum, Dorothy Wavinya Nyamai, Nasir Jalal, Peter Sh |
- Page last reviewed:Feb 1, 2024
- Content source: